MMB-CHMICA

MMB-CHMICA
Clinical data
Other names	AMB-CHMICA
Legal status
Legal status	CA: Schedule II ; DE: NpSG (Industrial and scientific use only) ; UK: Under Psychoactive Substances Act ; US: Schedule I ;
Identifiers
	IUPAC name Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-L-valinate;
CAS Number	1971007-94-9 ;
ChemSpider	68896113;
UNII	HEN6ZCR7GD;
CompTox Dashboard (EPA)	DTXSID301009991 ;
Chemical and physical data
Formula	C22H30N2O3
Molar mass	370.493 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)[C@@H](C(=O)OC)NC(=O)c1cn(c2c1cccc2)CC3CCCCC3;
	InChI InChI=1S/C22H30N2O3/c1-15(2)20(22(26)27-3)23-21(25)18-14-24(13-16-9-5-4-6-10-16)19-12-8-7-11-17(18)19/h7-8,11-12,14-16,20H,4-6,9-10,13H2,1-3H3,(H,23,25)/t20-/m0/s1; Key:ROWZIXRLVUOMCJ-FQEVSTJZSA-N;

MMB-CHMICA (AMB-CHMICA) is a designer drug and synthetic cannabinoid.[1][2][3] In 2018, it was the sixth-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration.[4]

References

Göl E, Çok I (January 2019). "New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey". Forensic Science International. 294: 113–123. doi:10.1016/j.forsciint.2018.11.003. PMID 30502695.
Mardal M, Dalsgaard PW, Qi B, Mollerup CB, Annaert P, Linnet K (April 2018). "E". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1083: 189–197. doi:10.1016/j.jchromb.2018.03.016. PMID 29549742.
Wagmann, Lea; Stiller, Rebecca G.; Fischmann, Svenja; Westphal, Folker; Meyer, Markus R. (July 2022). "Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases". Archives of Toxicology. doi:10.1007/s00204-022-03332-z. ISSN 1432-0738. PMID 35788413.
"Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Göl E, Çok I (January 2019). "New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey". Forensic Science International. 294: 113–123. doi:10.1016/j.forsciint.2018.11.003. PMID 30502695.

[2] Mardal M, Dalsgaard PW, Qi B, Mollerup CB, Annaert P, Linnet K (April 2018). "E". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1083: 189–197. doi:10.1016/j.jchromb.2018.03.016. PMID 29549742.

[3] Wagmann, Lea; Stiller, Rebecca G.; Fischmann, Svenja; Westphal, Folker; Meyer, Markus R. (July 2022). "Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases". Archives of Toxicology. doi:10.1007/s00204-022-03332-z. ISSN 1432-0738. PMID 35788413.

[4] "Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.